Literature DB >> 20229208

Toxic leukoencephalopathy after heroin abuse without heroin vapor inhalation: MR imaging and clinical features in three patients.

Stella Blasel1, Elke Hattingen, Michael Adelmann, Michael Nichtweiß, Friedhelm Zanella, Stefan Weidauer.   

Abstract

BACKGROUND AND
PURPOSE: Toxic leukoencephalopathy has been associated with illicit heroin vapor inhalation. Despite the nonspecific and variable clinical presentation of these patients, they show typical radiologic findings. Previous studies evaluated typical radiologic findings with symmetric infratentorial hyperintense signal changes and similar alteration in the posterior limb of the internal capsule, the splenium of corpus callosum, the medial lemniscus and the lateral brainstem. In context with the reviewed literature, a series of another three cases with toxic leukoencephalopathy after heroin abuse other than vapor inhalation is presented. PATIENTS AND METHODS: All three patients underwent magnet resonance imaging (MRI) including additional diffusion- weighted imaging and apparent diffusion coefficient maps. Clinical and laboratory findings were recorded.
RESULTS: MRI of all three patients revealed similar symmetric supratentorial hyperintense signal changes involving the frontal, parietal, occipital and temporal lobes. The cortex was spared and the subcortical U fibers were partially involved. Further, the brainstem and the cerebellar white matter were not affected.
CONCLUSION: Toxic leukoencephalopathy without involvement of the cerebellum and brainstem is a rare complication of heroin abuse. The pattern of heroin-induced toxic leukoencephalopathy on MRI might not only be related to an unknown adulterant, but also to the mode of drug administration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20229208     DOI: 10.1007/s00062-010-0022-9

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN: 1869-1439            Impact factor:   3.649


  32 in total

1.  Chasing the dragon--neurological toxicity associated with inhalation of heroin vapour: case report.

Authors:  M D Hill; P W Cooper; J R Perry
Journal:  CMAJ       Date:  2000-01-25       Impact factor: 8.262

Review 2.  [Spongiform leucoencephalopathy after inhaling illicit heroin and due to carbon monoxide-intoxication].

Authors:  P J Egan; F-W Becker; F Schumm
Journal:  Fortschr Neurol Psychiatr       Date:  2004-01       Impact factor: 0.752

Review 3.  "Chasing the dragon"--imaging of heroin inhalation leukoencephalopathy.

Authors:  Jeffrey Hagel; Gordon Andrews; Talia Vertinsky; Manraj K S Heran; Ciaran Keogh
Journal:  Can Assoc Radiol J       Date:  2005-10       Impact factor: 2.248

4.  Leucoencephalopathy after inhalation of heroin: a case report.

Authors:  E G Celius; S Andersson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

5.  Leukoencephalopathy after inhalation of heroin vapor.

Authors:  Y J Chang; C H Tsai; C J Chen
Journal:  J Formos Med Assoc       Date:  1997-09       Impact factor: 3.282

6.  Toxic spongiform leucoencephalopathy after inhaling heroin vapour.

Authors:  W Weber; H Henkes; P Möller; K Bade; D Kühne
Journal:  Eur Radiol       Date:  1998       Impact factor: 5.315

7.  Leucoencephalopathy after inhaling "heroin" pyrolysate.

Authors:  E C Wolters; G K van Wijngaarden; F C Stam; H Rengelink; R J Lousberg; M E Schipper; B Verbeeten
Journal:  Lancet       Date:  1982-12-04       Impact factor: 79.321

8.  Leukoencephalopathy and raised brain lactate from heroin vapor inhalation ("chasing the dragon")

Authors:  A R Kriegstein; D C Shungu; W S Millar; B A Armitage; J C Brust; S Chillrud; J Goldman; T Lynch
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

9.  Spongiform leucoencephalopathy following intravenous heroin abuse: radiological and histopathological findings.

Authors:  A S Robertson; S Jain; R A O'Neil
Journal:  Australas Radiol       Date:  2001-08

10.  Heroin-induced leukoencephalopathy: characterization using MRI, diffusion-weighted imaging, and MR spectroscopy.

Authors:  C Offiah; E Hall
Journal:  Clin Radiol       Date:  2007-10-24       Impact factor: 2.350

View more
  8 in total

1.  Selective injury of the globus pallidus and hippocampus in methamphetamine-induced encephalopathy.

Authors:  D W Kim; H J Im; J Oh
Journal:  Clin Neuroradiol       Date:  2011-11-24       Impact factor: 3.649

2.  Toxic leukoencephalopathy after intravenous heroin injection: a case with clinical and radiological reversibility.

Authors:  Corrado Villella; Raffaele Iorio; Gianluigi Conte; Anna Paola Batocchi; Pietro Bria
Journal:  J Neurol       Date:  2010-06-18       Impact factor: 4.849

3.  Heroin spongiform leukoencephalopathy (HSLE).

Authors:  A G Bach; B Jordan; N A Wegener; C Rusner; M Kornhuber; J Abbas; A Surov
Journal:  Clin Neuroradiol       Date:  2012-10-04       Impact factor: 3.649

4.  Toxic leucoencephalopathy after 'chasing the dragon'.

Authors:  Rajinder Singh; Monica Saini
Journal:  Singapore Med J       Date:  2015-06       Impact factor: 1.858

Review 5.  Differential diagnosis of white matter lesions: Nonvascular causes-Part II.

Authors:  S Weidauer; M Nichtweiss; E Hattingen
Journal:  Clin Neuroradiol       Date:  2014-02-12       Impact factor: 3.649

6.  Leukoencephalopathy due to inhalational and trans-conjunctival heroin abuse: First case report from Pakistan.

Authors:  Mohammad Suleman Bajwa; Hassan Nawaz; Muhammad Aemaz Ur Rehman; Sadaf Iftikhar; Abu Hurera
Journal:  Ann Med Surg (Lond)       Date:  2022-02-05

7.  Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient with Opioid Use Disorder.

Authors:  Terence Tumenta; Samuel Adeyemo; Oluwatoyin Oladeji; Oluwole Jegede; Bordes Laurent; Tolu Olupona
Journal:  Case Rep Psychiatry       Date:  2021-06-16

Review 8.  Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: A systematic review.

Authors:  Erin L Winstanley; James J Mahoney; Felipe Castillo; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2021-06-24       Impact factor: 4.492

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.